Tokman Alexander Y 4
4 · ENDRA Life Sciences Inc. · Filed Mar 30, 2022
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2022-03-28+109,323→ 109,323 totalExercise: $0.38Exp: 2032-03-28→ Common Stock (109,323 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.